Rabeprazole en es it fr

Rabeprazole Brand names, Rabeprazole Analogs

Rabeprazole Brand Names Mixture

  • No information avaliable

Rabeprazole Chemical_Formula


Rabeprazole RX_link


Rabeprazole fda sheet

Rabeprazole FDA

Rabeprazole msds (material safety sheet)

Rabeprazole Synthesis Reference

No information avaliable

Rabeprazole Molecular Weight

359.444 g/mol

Rabeprazole Melting Point

No information avaliable

Rabeprazole H2O Solubility

No information avaliable

Rabeprazole State

No information avaliable

Rabeprazole LogP


Rabeprazole Dosage Forms

Tablet (enteric-coated)

Rabeprazole Indication

For short-term treatment in the healing and symptomatic relief of erosive or ulcerative gastroesophageal reflux disease (GERD).

Rabeprazole Pharmacology

Rabeprazole prevents the production of acid in the stomach. It reduces symptoms and prevents injury to the esophagus or stomach in patients with gastroesophageal reflux disease (GERD) or ulcers. Rabeprazole is also useful in conditions that produce too much stomach acid such as Zollinger-Ellison syndrome. Rabeprazole may also be used with antibiotics to get rid of bacteria that are associated with some ulcers. Rabeprazole is a selective and irreversible proton pump inhibitor, suppresses gastric acid secretion by specific inhibition of the H+, K+ -ATPase enzyme system which is found at the secretory surface of parietal cells. It inhibits the final transport of hydrogen ions (via exchange with potassium ions) into the gastric lumen.

Rabeprazole Absorption

Absolute bioavailability is approximately 52%.

Rabeprazole side effects and Toxicity

No information avaliable

Rabeprazole Patient Information

No information avaliable

Rabeprazole Organisms Affected

Humans and other mammals